Nausea and Vomiting, Postoperative Clinical Trial
Official title:
Intrathecal Fentanyl Versus Intravenous Granisetron for the Prevention of Perioperative Nausea and Vomiting During Cesarean Delivery Under Spinal Anesthesia
Intrathecal Fentanyl Versus Intravenous Granisetron for the Prevention of Perioperative Nausea and Vomiting During Cesarean Delivery under Spinal Anesthesia
This prospective randomized control study will be held in Sohag University Hospital After approval of local ethics committee of sohag university hospital from June 2022 to December 2022, written informed consent will be taken from all patients , about advantages and possible complications of this study . Inclusion criteria This study will include 90 Patients , physical status I or II according to ASA classification , age between ( 18 - 45 years ) undergoing cesarean delivery under spinal anesthesia. Technique : On arrival of patient to operative room : 1. 20G IV line ( cannula ) will be inserted . 2. Putting of patient on monitor and assessment of hemodynamics ( HR , RR , BP ) . 3. Pre anesthetic hydration by at least 1000 ml ringer lactate 4. Patient received Spinal anesthesia at level L3-L4 or L4-L5 lumbar segement . 5. during the procedure, If patient suffer from : - brady cardia with heart rate ( HR ) less than 55 we will give atropine sulphate 0.5 mg IV . - hypotension less than 25% of MBP of preoperative value we will give normal saline or ephedrine 5-10 mg . 6. Putting patient in the position for the operation . Patients will be prospectively randomized divided into 3 groups : The patients will be randomized using closed envelope method and the medications will be prepared by another anaesthologist not sharing in the study Group ( F ) Fentanyl group : ( n = 30 ) Patients will receive 10 mg hyperbaric Bupivacaine ( 2ml ) and 20 μg (0.5 mL) fentanyl IT. 1 mL IV normal saline immediately after the placement of the spinal. Group ( G ) Granisetron group : ( n = 30 ) Patients will receive 10 mg hyperbaric Bupivacaine ( 2ml ) and 0.5 mL normal saline IT. 1 mg (1 mL) IV granisetron after spinal placement. Group ( C ) Control group : ( n = 30 ) 10 mg hyperbaric Bupivacaine ( 2ml ) IT and normal saline 0.5 ml 1 ml normal saline IV after spinal placement. \Data will be collected from this study : ( 1 ) : Demographic data : Age , sex , weight , height and duration of operation . ( 2 ) : intraoperative: A- hemodynamics (HR , BP , RR , oxygen saturation before anesthesia , after induction and then : Every 5 minutes for 1st hour Every 15 minutes for next 2 hours Then every 3 hour for 12 h post operative . B - nausea and vomiting. C - patient discomfort during anesthesia. D - itching. ( 3 ) : post operative : A - nausea and vomiting : using nausea and vomiting score. B - pain assessment using VAS : every 30 mins for 2 h , every hour for 12 h If VAS 3-5 we will give paracetamol 1g IV , more than 5 we will give ketrolac 30 mg IV C _ total analgesic consumption D _ itching F _ retention of urine ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01217190 -
Crossover Study Comparing Ondansetron Orally Dissolving Film Strip (ODFS) With Zofran Orally Disintegrating Tablets
|
Phase 1/Phase 2 | |
Recruiting |
NCT06302673 -
The Role Of Laserpuncture For Prevention Of Nausea And Vomiting Post Strabismus Surgery With General Anesthesia In Adult Patients
|
N/A | |
Recruiting |
NCT04563494 -
The Effects of IV vs Oral Dexamethasone on Postoperative Nausea, Vomiting, and Pain
|
Phase 4 | |
Completed |
NCT00108095 -
A Study To Evaluate An NK-1 Antiemetic For The Prevention Of Post Operative Nausea And Vomiting
|
Phase 2 | |
Not yet recruiting |
NCT05426278 -
The Effect Of Intraoperative Forced Air Warmer Use, On Postoperative Nausea And Vomiting
|
N/A | |
Withdrawn |
NCT04954365 -
Post Operative Nausea and Vomiting (PONV) Rescue Outcomes After Amisulpride Treatment
|
||
Not yet recruiting |
NCT06356623 -
A Risk Prediction Model of Postoperative Nausea and Vomiting in Patients With Liver Cancer
|
||
Withdrawn |
NCT05016076 -
Multi-Strategy Intervention for Anesthesia Care of Obese Patients A Factorial Randomized Controlled Trial
|
N/A | |
Not yet recruiting |
NCT04899817 -
Granisteron Versus Metoclopramide in Laparoscopic Cholecystectomy
|
Phase 4 | |
Recruiting |
NCT05875077 -
Propofol Versus Dexmedetomidine on the Incidence of Postoperative Nausea and Vomiting
|
N/A | |
Completed |
NCT03338400 -
Dexamethasone Administration To Improve Patient Recovery In Ambulatory Vaginal Prolapse Surgery: Is There A Role?
|
Phase 2 | |
Completed |
NCT05692245 -
Dexamethasone vs Ondansetron After Cesarean Delivery
|
Phase 4 | |
Completed |
NCT03125941 -
High vs Low Dose Dexamethasone on Complications in the Immediate Postoperative Phase After Mastectomy
|
Phase 4 | |
Completed |
NCT00326248 -
Casopitant (Oral) And ZOFRAN To Prevent Postoperative Nausea And Vomiting In Women
|
Phase 3 | |
Completed |
NCT00334152 -
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
|
Phase 3 | |
Recruiting |
NCT03586817 -
PALONOSETRON X FOSAPREPITANT IN PONV
|
Phase 4 | |
Not yet recruiting |
NCT06357234 -
Aprepitant Treatment to Prevent Postoperative Nausea and Vomiting in Children Undergoing Scoliosis Surgery
|
Phase 2 | |
Completed |
NCT03045133 -
QUALITY OF RECOVERY AFTER INTRAOPERATIVE MORPHINE OR METHADONE
|
Phase 4 | |
Not yet recruiting |
NCT06410365 -
Impact of Intrathecal vs Intravenous Dexmedetomidine
|
Phase 4 | |
Enrolling by invitation |
NCT05439798 -
Effect of Palonosetron, Ondansetron and Dexamethasone in the Prevention of Postoperative Nausea and Vomiting
|
Phase 3 |